John Sperzel

2022

In 2022, John Sperzel earned a total compensation of $2M as President, Chief Executive Officer and Chairman of the Board of Directors at T2 Biosystems, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$287,500
Salary$575,000
Stock Awards$1,119,840
Other$3,000
Total$1,985,340

Sperzel received $1.1M in stock awards, accounting for 56% of the total pay in 2022.

Sperzel also received $287.5K in non-equity incentive plan, $575K in salary and $3K in other compensation.

Rankings

In 2022, John Sperzel's compensation ranked 1,758th out of 5,694 executives tracked by ExecPay. In other words, Sperzel earned more than 69.1% of executives.

ClassificationRankingPercentile
All
1,758
out of 5,694
69th
Division
Manufacturing
919
out of 3,099
70th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
114
out of 475
76th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
75
out of 340
78th
Industry
Surgical and Medical Instruments and Apparatus
63
out of 246
74th
Source: SEC filing on July 26, 2023.

Sperzel's colleagues

We found two more compensation records of executives who worked with John Sperzel at T2 Biosystems in 2022.

2022

Michael Gibbs

T2 Biosystems

General Counsel

2022

John Sprague

T2 Biosystems

Chief Financial Officer

News

You may also like